Article

Apraclonidine for the Diagnosis of Horner Syndrome

A Closer Look

Author and Disclosure Information

When the clinical signs of this syndrome leave some doubt, pharmacologic testing helps confirm the diagnosis. These two cases illustrate the potential for apraclonidine to replace the more traditional, but problematic, topical cocaine in this capacity.


 

Recommended Reading

Disruptive Behaviors in Dementia: Promoting Nonpharmacologic Intervention Through Staff Education
Federal Practitioner
Preventing Falls in Older Adults with Dementia
Federal Practitioner
Brain Injuries from Falls
Federal Practitioner
First Drug Approved to Treat Huntington Chorea
Federal Practitioner
The Blow by Blow on Head Injury
Federal Practitioner
ALS Joins List of Presumed Service-Connected Conditions
Federal Practitioner
Peripheral Neuropathy in a Patient Taking Ciprofloxacin
Federal Practitioner
Does Donepezil Boost Benefits of Cognitive Training?
Federal Practitioner
Using the Glasgow Coma Scale to Predict TBI Outcomes
Federal Practitioner
When Veterans Reach Out to Other Veterans, Everyone Benefits: The Exchange Club Experience
Federal Practitioner